Evidence map›Paper›PMID 41742976›Full record

ArticleCureus2026

Pauci-Immune Crescentic Glomerulonephritis Associated With Primary Sjögren Syndrome: A Case Report.

Fabian M Rivas Vega, María F Mendoza Rodriguez, Jaime Loeza-Suárez

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fabian M Rivas VegaInternal Medicine, Hospital Juárez de México, Mexico City, MEX.
María F Mendoza RodriguezInternal Medicine, Hospital Juárez de México, Mexico City, MEX.
Jaime Loeza-SuárezInternal Medicine, Hospital Juárez de México, México City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Sjögren syndrome (SS) is a chronic systemic autoimmune disease predominantly characterized by exocrine gland involvement; however, extraglandular manifestations, including renal involvement, may occur and contribute significantly to morbidity. Renal involvement most commonly presents as tubulointerstitial nephritis, while glomerular disease is considerably less frequent. Pauci-immune crescentic glomerulonephritis (GN) is an exceptionally rare renal manifestation of primary SS and is typically associated with antineutrophil cytoplasmic antibody (ANCA)-related vasculitis, although antibody negativity has been described in isolated cases. We report the case of a 30-year-old female with no significant past medical history who presented with hypertensive crisis and rapidly progressive renal dysfunction. Laboratory evaluation revealed acute kidney injury with significant proteinuria. Further evaluation identified sicca symptoms, positive antinuclear antibodies at high titers, and elevated anti-SS-related antigen A antibodies, with normal complement levels and negative ANCAs. Minor salivary gland biopsy confirmed the diagnosis of primary SS. Renal biopsy demonstrated pauci-immune crescentic GN with advanced chronic changes and absence of immune complex deposition on immunofluorescence. The patient was treated with intravenous pulse corticosteroids, resulting in improvement of renal function. This report highlights a rare and atypical form of renal involvement in primary SS and underscores the importance of considering pauci-immune GN in patients with SS presenting with rapidly progressive renal failure, even in the absence of ANCAs. Early recognition and prompt histopathological diagnosis are essential to guide appropriate immunosuppressive therapy and improve renal outcomes.

Indexed as

anca negativepauci-immune crescentic glomerulonephritisprimary sjögren's syndromerapidly progressive glomerulonephritis (rpgn)renal biopsyrenal involvementsjögren syndrome

Identifiers

PMID41742976
PMCPMC12931569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.